EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Diagnostic tools to establish the presence and severity of peripheral arterial disease in people with diabetes: a synopsis of the DM PAD prospective multicentre diagnostic accuracy study

Diagnostische Werkzeuge zum Nachweis von peripherer arterieller Verschlusskrankheit und deren Schweregrad bei Menschen mit Diabetes: Synopsis der prospektiven multizentrischen DM PAD-Diagnostikstudie

Laura Burgess iD, Pasha Normahani iD, John Norrie iD, Sharon Tuck iD, Catriona Graham iD, David Mark Epstein iD, Neghal Kandiyil iD, Athanasios Saratzis iD, Francine Heatley iD, Sasha Smith iD, Kamlesh Khunti iD, David Wingfield iD und 8 weitere

Health Technology Assessment · 2026-03 · 1-22

DOI: 10.3310/gjuj2819 ↗

Auf einen Blick

In 573 Referenztests bei Menschen mit Diabetes war die diagnostische Genauigkeit der routinemäßig verwendeten Bettseitentests gering. Der Podiatry Ankle Duplex scan zeigte die höchste Sensitivität.

Fragestellung

Wie genau erkennen fünf Bettseitentests periphere arterielle Verschlusskrankheit bei Menschen mit Diabetes im Vergleich zu CTA/MRA als Referenztest?

Methode

Prospektive multizentrische Diagnostikstudie in Primär- und Sekundärversorgung im Vereinigten Königreich; Vergleich von fünf Indextests, in drei Zentren zusätzlich Podiatry Ankle Duplex scan; Referenztest CTA oder MRA innerhalb von 6 Wochen.

Ergebnisse

222 von 573 Teilnehmenden (39 %) hatten eine periphere arterielle Verschlusskrankheit. Sensitivität: hörbare Wellenform 36 % (99 %-KI 27 %–45 %), visuelle Wellenform 42 % (33 %–51 %), Toe–brachial pressure index 55 % (46 %–64 %), Ankle–brachial pressure index 41 % (32 %–50 %), Exercise ankle–brachial pressure index 41 % (31 %–51 %). Podiatry Ankle Duplex scan: 89 % (74 %–100 %).

Einschränkungen

45 % der Referenzscans lagen außerhalb des 6-Wochen-Fensters; Prävalenz niedriger als geplant (39 % vs. 50 %); mögliche Beeinflussung der Testinterpretation.

Schlussfolgerung der Autor:innen

Die in der klinischen Praxis routinemäßig verwendeten Indextests zeigten bei Menschen mit Diabetes eine schlechte diagnostische Genauigkeit für periphere arterielle Verschlusskrankheit und sollten dafür nicht empfohlen werden.

Kernaussagen

  • 39 % der 573 Referenztests waren positiv
  • Routinetests zeigten nur geringe Sensitivitäten
  • Podiatry Ankle Duplex scan hatte die höchste Sensitivität

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Multizentrische Studie in der Zeitschrift Health Technology Assessment, 2026-03. Verfasst von Laura Burgess und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Cancer, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Peripheral Arterial Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Technology Assessment programme.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peripheral arterial disease is a major cause of the development of diabetic foot ulcers, lower limb amputation and mortality in patients with diabetes. Diagnosing peripheral arterial disease is of clinical importance but is difficult in this cohort of patients. Several diagnostic bedside tests exist, but there is uncertainty as to which is the most accurate. Objective(s) To determine the diagnostic accuracy of five index tests (audible waveform assessment, visual waveform assessment, toe–brachial pressure index, ankle–brachial pressure index and exercise ankle–brachial pressure index) for the diagnosis of peripheral arterial disease in patients with diabetes as determined by a reference test (computed tomography angiography or magnetic resonance angiography). In selected sites, to evaluate the performance of a sixth test, the Podiatry Ankle Duplex scan, a new point-of-care duplex ultrasound scan. Design and methods Prospective multicentre diagnostic accuracy study.

Setting

Primary (general practice and community clinics) and secondary care National Health Service hospitals (inpatient and outpatient) in the United Kingdom.

Participants

Patients were eligible for inclusion if they were aged ≥ 18 years and had a known history of diabetes. Exclusion criteria included contraindications to computed tomography angiography or magnetic resonance angiography, if their peripheral arterial disease status was known on imaging, or they had a known history of peripheral arterial disease intervention.

Interventions

Participants underwent all bedside tests (Podiatry Ankle Duplex scan performed in three centres only), which were performed in a logical sequence to reduce the risk of bias. The reference scan was to be performed within 6 weeks of the index tests. Main outcome measures The primary outcome measure of diagnostic performance is test sensitivity. Secondary outcomes included specificity, likelihood ratios, predictive values and diagnostic odds ratio, as well as patient acceptability of tests, technical success and health economic outcomes.

Results

Based on the 573 reference tests performed, 222 (39%) participants had evidence of peripheral arterial disease. All routinely used index tests showed relatively low sensitivities: audible waveform 36%, 99% confidence interval 27% to 45%; visual waveform 42%, confidence interval 33% to 51%; toe–brachial pressure index 55%, confidence interval 46% to 64%; ankle–brachial pressure index 41%, confidence interval 32% to 50%; and exercise ankle–brachial pressure index 41%, confidence interval 31% to 51%. The Podiatry Ankle Duplex scan had a higher sensitivity 89%, confidence interval 74% to 100%, as compared to all other index tests.

Limitations

A large proportion of reference scans were performed outside the 6-week time window (45%), although peripheral arterial disease is a chronic condition and is unlikely to have developed/progressed in the time frame. Additionally, the peripheral arterial disease prevalence was lower than anticipated during study design (39% vs. 50%). Lastly, despite efforts to standardise assessment and minimise bias, there is the possibility that one test may have influenced the interpretation of others.

Conclusions

Index tests used routinely in clinical practice for diagnosing peripheral arterial disease in patients with diabetes showed poor diagnostic accuracy for peripheral arterial disease and should not be recommended for diagnosing peripheral arterial disease in this population. Future work A review of peripheral arterial disease diagnostic testing in patients with diabetes should be undertaken. It may be necessary to perform more reliable imaging, such as full lower limb duplex ultrasound as a first-line diagnostic test. Funding This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number NIHR131855.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Arterial DiseaseHumansFemaleProspective StudiesMaleAnkle Brachial IndexAgedUnited KingdomMiddle AgedSeverity of Illness IndexMagnetic Resonance AngiographyComputed Tomography AngiographySensitivity and SpecificityCost-Benefit Analysis

Stichwörter der Autor:innen

CARDIOVASCULAR DISEASECOST-EFFECTIVENESSDIABETIC FOOTPERIPHERAL ARTERIAL DISEASE

Autor:innen und Institutionen

  • Department of Surgery and Cancer, Imperial College London, London, UK.
  • Vascular Unit, Imperial College Healthcare NHS Trust, London, UK.
  • Usher Institute, Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK.
  • Edinburgh Clinical Trials Unit, Edinburgh, UK.
  • Edinburgh Clinical Research Facility, University of Edinburgh, Edinburgh, UK.
  • Faculty of Economics and Business Sciences, University of Granada, Granada, Spain.

ORCID-Profile: Laura Burgess, Pasha Normahani, John Norrie, Sharon Tuck, Catriona Graham, David Mark Epstein, Neghal Kandiyil, Athanasios Saratzis, Francine Heatley, Sasha Smith, Kamlesh Khunti, David Wingfield, Tim Hartshorne, Simon Ashwell, Joseph Shalhoub, Elizabeth Pigott, Alun H Davies, Usman Jaffer

Förderung

  • Health Technology Assessment programme

Zitieren

APA

Burgess, L., Normahani, P., Norrie, J., Tuck, S., Graham, C., Mark Epstein, D., Kandiyil, N., Saratzis, A., Heatley, F., Smith, S., Khunti, K., Wingfield, D., Coward, T., Hartshorne, T., Ashwell, S., Shalhoub, J., Pigott, E., Davies, A. H., Jaffer, U., & DM PAD Trial Investigators (2026). Diagnostic tools to establish the presence and severity of peripheral arterial disease in people with diabetes: a synopsis of the DM PAD prospective multicentre diagnostic accuracy study. Health Technology Assessment, 1-22. https://doi.org/10.3310/gjuj2819

Vancouver

Burgess L, Normahani P, Norrie J, Tuck S, Graham C, Mark Epstein D, et al. Diagnostic tools to establish the presence and severity of peripheral arterial disease in people with diabetes: a synopsis of the DM PAD prospective multicentre diagnostic accuracy study. Health Technology Assessment. 2026:1-22. doi:10.3310/gjuj2819

BibTeX
@article{Burgess2026,
  author = {Burgess, Laura and Normahani, Pasha and Norrie, John and Tuck, Sharon and Graham, Catriona and Mark Epstein, David and Kandiyil, Neghal and Saratzis, Athanasios and Heatley, Francine and Smith, Sasha and Khunti, Kamlesh and Wingfield, David and Coward, Trusha and Hartshorne, Tim and Ashwell, Simon and Shalhoub, Joseph and Pigott, Elizabeth and Davies, Alun H and Jaffer, Usman and DM PAD Trial Investigators, DM PAD Trial Investigators},
  title = {Diagnostic tools to establish the presence and severity of peripheral arterial disease in people with diabetes: a synopsis of the DM PAD prospective multicentre diagnostic accuracy study},
  journal = {Health Technology Assessment},
  year = {2026},
  pages = {1--22},
  doi = {10.3310/gjuj2819}
}
Kostenlos starten →